MarketBeat Daily Ratings for Tuesday, February 11, 2025
Ratings changes for Healthcare Services Group, XOMA, Super Micro Computer, Fluence Energy, Qurate Retail, Cyclacel Pharmaceuticals, Moderna and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.February 11th, 2025 Today's Top Stories | | By Sam Quirke | February 10, 2025 08:42 AM |
| | | By The Associated Press | February 11, 2025 06:09 AM |
| | By Sam Quirke | February 10, 2025 09:12 AM |
| | | By The Associated Press | February 10, 2025 11:13 PM |
| | By Gabriel Osorio-Mazilli | February 11, 2025 07:45 AM |
|
|
Analysts' Upgrades | | Allient (NASDAQ:ALNT) was upgraded by analysts at Northland Securities from a "market perform" rating to an "outperform" rating. They now have a $35.00 price target on the stock, up previously from $30.00. This represents a 34.6% upside from the current price of $26.01. | | Brixmor Property Group (NYSE:BRX) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $31.00 price target on the stock. This represents a 15.5% upside from the current price of $26.83. | | Compass (NYSE:COMP) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $11.00 price target on the stock, up previously from $7.00. This represents a 41.8% upside from the current price of $7.76. | | First Solar (NASDAQ:FSLR) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $259.00 price target on the stock, up previously from $218.00. This represents a 58.1% upside from the current price of $163.82. | | Southwest Airlines (NYSE:LUV) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $35.00 price target on the stock. This represents a 16.7% upside from the current price of $30.00. | | monday.com (NASDAQ:MNDY) was upgraded by analysts at KeyCorp from a "sector weight" rating to an "overweight" rating. They now have a $420.00 price target on the stock. This represents a 27.1% upside from the current price of $330.48. | | Peloton Interactive (NASDAQ:PTON) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $15.00 price target on the stock. This represents a 72.0% upside from the current price of $8.72. | | RTX (NYSE:RTX) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating.The current price is $128.35. | | Super Micro Computer (NASDAQ:SMCI) was upgraded by analysts at Cfra from a "hold" rating to a "buy" rating. They now have a $48.00 price target on the stock. This represents a 15.0% upside from the current price of $41.75. | | Steel Dynamics (NASDAQ:STLD) was upgraded by analysts at KeyCorp from a "sector weight" rating to an "overweight" rating. They now have a $155.00 price target on the stock. This represents a 15.8% upside from the current price of $133.88. | | TXNM Energy (NYSE:TXNM) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $54.00 price target on the stock, up previously from $51.00. This represents a 10.1% upside from the current price of $49.07. |
|
View More Upgrades
|
Analysts' Downgrades | | Columbus McKinnon (NASDAQ:CMCO) was downgraded by analysts at DA Davidson from a "buy" rating to a "neutral" rating. They now have a $35.00 price target on the stock. This represents a 57.0% upside from the current price of $22.29. | | Dynavax Technologies (NASDAQ:DVAX) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "sell" rating. They now have a $12.00 price target on the stock, down previously from $15.00. This represents a 3.1% downside from the current price of $12.38. | | Equifax (NYSE:EFX) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating.The current price is $250.67. | | Fluence Energy (NASDAQ:FLNC) was downgraded by analysts at Guggenheim from a "buy" rating to a "sell" rating. They now have a $6.00 price target on the stock, down previously from $26.00. This represents a 12.8% downside from the current price of $6.88. | | Fluence Energy (NASDAQ:FLNC) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to a "market perform" rating. They now have a $10.00 price target on the stock, down previously from $22.00. This represents a 45.4% upside from the current price of $6.88. | | First National (NASDAQ:FXNC) was downgraded by analysts at Hovde Group from an "outperform" rating to a "market perform" rating. They now have a $28.50 price target on the stock. This represents a 9.1% upside from the current price of $26.13. | | Cloudflare (NYSE:NET) was downgraded by analysts at DZ Bank AG from a "hold" rating to a "sell" rating. They now have a $145.00 price target on the stock. This represents a 15.1% downside from the current price of $170.83. | | Playa Hotels & Resorts (NASDAQ:PLYA) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating. They now have a $13.50 price target on the stock, down previously from $15.00. This represents a 1.8% upside from the current price of $13.26. | | Playa Hotels & Resorts (NASDAQ:PLYA) was downgraded by analysts at Oppenheimer Holdings Inc. from an "outperform" rating to a "market perform" rating.The current price is $13.26. | | Q32 Bio (NASDAQ:QTTB) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $4.00 price target on the stock, down previously from $20.00. This represents a 37.5% upside from the current price of $2.91. | | Q32 Bio (NASDAQ:QTTB) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to a "market perform" rating. They now have a $3.00 price target on the stock, down previously from $22.00. This represents a 3.1% upside from the current price of $2.91. | | REGENXBIO (NASDAQ:RGNX) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $14.00 price target on the stock, down previously from $38.00. This represents a 89.7% upside from the current price of $7.38. | | Snap (NYSE:SNAP) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.The current price is $10.61. | | TechTarget (NASDAQ:TTGT) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.The current price is $17.04. |
|
View More Downgrades
|
Analysts' New Coverage | | ACADIA Pharmaceuticals (NASDAQ:ACAD) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "hold" rating and a $22.00 price target on the stock. This represents a 19.6% upside from the current price of $18.39. | | Alkermes (NASDAQ:ALKS) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $40.00 price target on the stock. This represents a 27.4% upside from the current price of $31.40. | | Avadel Pharmaceuticals (NASDAQ:AVDL) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $12.00 price target on the stock. This represents a 34.8% upside from the current price of $8.90. | | Axsome Therapeutics (NASDAQ:AXSM) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $176.00 price target on the stock. This represents a 31.5% upside from the current price of $133.81. | | AZZ (NYSE:AZZ) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $108.00 price target on the stock. This represents a 11.2% upside from the current price of $97.12. | | Biohaven (NYSE:BHVN) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $65.00 price target on the stock. This represents a 60.3% upside from the current price of $40.54. | | Biogen (NASDAQ:BIIB) is now covered by analysts at Sanford C. Bernstein. They set a "market perform" rating and a $160.00 price target on the stock. This represents a 13.9% upside from the current price of $140.42. | | Crinetics Pharmaceuticals (NASDAQ:CRNX) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.The current price is $35.84. | | Denali Therapeutics (NASDAQ:DNLI) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $31.00 price target on the stock. This represents a 46.7% upside from the current price of $21.13. | | Domo (NASDAQ:DOMO) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $11.00 price target on the stock. This represents a 20.0% upside from the current price of $9.17. | | ECARX (NASDAQ:ECX) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $3.20 price target on the stock. This represents a 65.4% upside from the current price of $1.94. | | Flex (NASDAQ:FLEX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $52.00 price target on the stock. This represents a 20.4% upside from the current price of $43.19. | | Gaia (NASDAQ:GAIA) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $10.00 price target on the stock. This represents a 89.8% upside from the current price of $5.27. | | Harmony Biosciences (NASDAQ:HRMY) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $55.00 price target on the stock. This represents a 44.5% upside from the current price of $38.07. | | International Business Machines (NYSE:IBM) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $320.00 price target on the stock. This represents a 27.2% upside from the current price of $251.61. | | Neurocrine Biosciences (NASDAQ:NBIX) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "hold" rating and a $138.00 price target on the stock. This represents a 19.4% upside from the current price of $115.59. | | Praxis Precision Medicines (NASDAQ:PRAX) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $111.00 price target on the stock. This represents a 37.6% upside from the current price of $80.69. | | Silence Therapeutics (NASDAQ:SLN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $6.00 price target on the stock. This represents a 34.6% upside from the current price of $4.46. | | Sarepta Therapeutics (NASDAQ:SRPT) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "hold" rating and a $136.00 price target on the stock. This represents a 22.6% upside from the current price of $110.96. | | Sunrise Realty Trust (NASDAQ:SUNS) is now covered by analysts at Keefe, Bruyette & Woods. They set an "outperform" rating and a $12.75 price target on the stock. This represents a 9.3% upside from the current price of $11.66. | | TTM Technologies (NASDAQ:TTMI) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $33.00 price target on the stock. This represents a 23.9% upside from the current price of $26.64. | | Waystar (NASDAQ:WAY) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $51.00 price target on the stock. This represents a 22.3% upside from the current price of $41.69. | | Xenon Pharmaceuticals (NASDAQ:XENE) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $67.00 price target on the stock. This represents a 73.0% upside from the current price of $38.73. |
|
View More New Coverage
|
Calendars from MarketBeat | |
|
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. | | Start Your 30-Day Free Trial |
| Upgrade Your Subscription | | Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | | Upgrade Now |
|
| Manage Your Watchlist | | View and add up to five holdings to your watchlist. | | View My Portfolio |
|
| Join Our Facebook Group | | Join MarketBeat’s free stock discussion and trading idea group on Facebook. | | Join Now |
|
Thank you for subscribing to MarketBeat!We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
© 2006-2025 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States. Today's Bonus Content: Elon Social Security shock? |
